- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALS (Amyotrophic Lateral Sclerosis) in Japan
Total 65 results
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Yoshino Neurology ClinicUnknownAmyotrophic Lateral SclerosisJapan
-
Chiba UniversityCompleted
-
Kyoto UniversityPfizer; Kitasato University; Tokushima University; Tottori UniversityRecruiting
-
Mitsubishi Tanabe Pharma CorporationCompletedJapanese Patients With ALSJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedJapanese Patients With ALSJapan
-
Mitsubishi Tanabe Pharma America Inc.CompletedAmyotrophic Lateral Sclerosis (ALS)United States, Canada, Japan, France, Germany, Italy
-
Eisai Co., Ltd.CompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Eisai Co., Ltd.CompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
BiogenRecruitingAmyotrophic Lateral Sclerosis Associated With a SOD1 Gene MutationUnited States, Canada, Spain, Australia, Germany, Italy, Japan, Korea, Republic of, United Kingdom, Belgium, Brazil, France, Poland, Sweden
-
Tokyo Medical UniversityCompleted
-
University of TokushimaEisai Co., Ltd.UnknownAmyotrophic Lateral SclerosisJapan
-
GlaxoSmithKlineCompletedAmyotrophic Lateral SclerosisUnited States, France, Australia, Canada, Belgium, Germany, Korea, Republic of, Japan, Netherlands, Italy, United Kingdom
-
Apellis Pharmaceuticals, Inc.TerminatedMotor Neuron Disease | Amyotrophic Lateral SclerosisUnited States, Netherlands, Spain, Germany, Japan, Australia, France, Poland, Ukraine, Belgium, Czechia, Ireland, Italy, United Kingdom
-
BiogenIonis Pharmaceuticals, Inc.CompletedAmyotrophic Lateral SclerosisUnited States, Canada, Belgium, France, Australia, Japan, Denmark, Korea, Republic of, United Kingdom, Germany, Italy, Poland
-
PTC TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Spain, Australia, Germany, Italy, Czechia, France, Netherlands, Japan, Poland, Argentina, Sweden
-
SanofiTerminatedAmyotrophic Lateral SclerosisNetherlands, China, Poland, Italy, Belgium, United States, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
Alexion PharmaceuticalsTerminatedAmyotrophic Lateral Sclerosis | ALSUnited States, Spain, Italy, Belgium, Canada, Switzerland, Australia, Germany, Denmark, Israel, Sweden, France, Ireland, United Kingdom, Japan, Netherlands, Poland
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
Gunma UniversityCompletedSystemic Sclerosis Patients With Digital UlcersJapan
-
Maruho Co., Ltd.Active, not recruiting
-
TakedaCompleted
-
Kyowa Kirin Co., Ltd.Active, not recruiting
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
Kyowa Kirin Co., Ltd.Active, not recruitingModerate to Severe Systemic SclerosisJapan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Tokyo UniversityJapan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.CompletedAutoimmune Diseases | Collagen Diseases | Scleroderma, Systemic | Lung Fibrosis | Skin SclerosisJapan
-
Mitsubishi Tanabe Pharma CorporationRecruiting
-
Mayo ClinicNagoya UniversityCompletedIgG4-related Disease | IgG4-related Sclerosing CholangitisUnited States, Japan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
NobelpharmaActive, not recruitingTuberous Sclerosis ComplexJapan
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
BiogenActive, not recruiting
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisJapan, Russian Federation
-
BiogenCompleted
-
NovartisMitsubishi Tanabe Pharma CorporationCompletedMultiple SclerosisJapan
-
Merck KGaA, Darmstadt, GermanyCompletedEmbryo Transfer | Luteal Hormone Supplementation in In-vitro FertilizationJapan
-
AmgenEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicKorea, Republic of, France, United States, Spain, Mexico, Japan, Argentina, Greece, Israel
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Novartis PharmaceuticalsTerminatedMultiple SclerosisBelgium, Spain, Russian Federation, France, Italy, Poland, Sweden, Turkey, Czech Republic, Japan
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
AmgenRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicUnited States, Korea, Republic of, Germany, Spain, Italy, Israel, Japan, Serbia, Argentina, Greece, Mexico, Poland, Chile, Austria, France, Portugal, Romania, Switzerland, United Kingdom
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States, Switzerland, Korea, Republic of, Australia, Netherlands, Israel, United Kingdom, Germany, Japan, Spain, Poland, Canada
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisChina, Japan
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more